Results

1–10 of 22 results for United States

Outcomes of Patients With Proliferative Diabetic Retinopathy Treated With Anti-VEGF Therapy and/or PRP in the United States Who Were Lost to Follow-up
Rahul N. Khurana, MD, FASRS
Annual Meeting Talks
2025
Treatment Response and Safety of Faricimab in Underrepresented Patients With DME: Year 1 Results From ELEVATUM in the United States
Andres Emanuelli, MD
Annual Meeting Talks
2025
Epidemiology of Inherited Retinal Diseases in the United States- IRIS Registry Intelligent Research In Sight Analysis
Ahmad Al-Moujahed, MD, PhD, MPH
Annual Meeting Talks
2023
The incidence and timing of treatment-requiring retinopathy of prematurity (ROP) in nanopremature and micropremature infants in the United States
Edward H. Wood, MD, FASRS
Annual Meeting Talks
2023
Type of Vitreoretinal Anesthesia and Sources of Variation in the United States
Ahmed Sallam, MD PhD FRCOphth
Annual Meeting Talks
2023
The MOSAIC Study: A Clinical and Humanistic Burden of Illness Study of Patients With GA and Their Caregivers in the United States and Canada
Sophie Jane Bakri, MD
Annual Meeting Talks
2023
A Multicenter Post-Authorization Safety Study of Patients Treated With Voretigene Neparvovec-rzyl Gene Therapy in the United States: Interim Analysis at 3 Years
Aaron Nagiel, MD, PhD
Annual Meeting Talks
2024
Temporal Trends and Regional Variations in Retinal Detachment Repair Procedures in the United States
Parisa Emami Naeini, MD, MPH, FASRS
Annual Meeting Talks
2024
Temporal Trends and Regional Variations in Retinal Detachment Repair Procedures in the United States
Parisa Emami Naeini, MD, MPH, FASRS
Updates from the Field
2024
Real-World Treatment Practices Among Newly Diagnosed Patients With Noninfectious Uveitis in the United States
On Demand Cases, Courses, and Papers
2022